Vanda Pharmaceuticals
VNDA
#7387
Rank
โ‚ฌ0.28 B
Marketcap
4,81ย โ‚ฌ
Share price
3.39%
Change (1 day)
51.74%
Change (1 year)

Revenue for Vanda Pharmaceuticals (VNDA)

Revenue in 2024 (TTM): โ‚ฌ0.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.16 Billion. In 2023 the company made a revenue of โ‚ฌ0.17 Billion a decrease over the revenue in the year 2022 that were of โ‚ฌ0.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vanda Pharmaceuticals from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.16 B-3.22%
2023 โ‚ฌ0.17 B-26.52%
2022 โ‚ฌ0.23 B-0.04%
2021 โ‚ฌ0.23 B17.59%
2020 โ‚ฌ0.20 B-0.51%
2019 โ‚ฌ0.20 B20.14%
2018 โ‚ฌ0.16 B22.69%
2017 โ‚ฌ0.13 B-0.89%
2016 โ‚ฌ0.13 B38.08%
2015 โ‚ฌ0.10 B143.78%
2014 โ‚ฌ41.23 M68.11%
2013 โ‚ฌ24.53 M-0.85%
2012 โ‚ฌ24.74 M2.75%
2011 โ‚ฌ24.07 M-10.31%
2010 โ‚ฌ26.84 M745.76%
2009 โ‚ฌ3.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ46.26 B 27,336.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ37.85 B 22,349.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ81.23 B 48,078.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ43.94 B 25,960.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ51.54 B 30,468.83%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ57.87 B 34,224.97%๐Ÿ‡บ๐Ÿ‡ธ USA